Search results for " Staging"

showing 10 items of 717 documents

Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.

2011

The aim of this study was to assess the effect of adjuvant anastrozole, alone or associated with risedronate, on BMD and bone fracture risk in women more than 70 years old with hormone receptor-positive early breast cancer (EBC). In a group of 51 elderly women (aged 76.4 ± 5.0 years) considered for adjuvant aromatase inhibitors for EBC, 24 patients with T-scores ≥ -2 and no prevalent fractures received anastrozole 1 mg/day (group A), and 27 patients with T-scores < -2, or with T-scores ≥ -2 and prevalent fractures (group B), received anastrozole (1 mg/day) plus risedronate (35 mg/week). Both groups received supplementation with 1 g calcium carbonate and 800 IU vitamin D per day. Differen…

Endocrinology Diabetes and MetabolismOsteoporosisSeverity of Illness IndexCohort StudiesEndocrinologyBone DensityOrthopedics and Sports MedicineVitamin DAromataseOsteoporosis PostmenopausalAged 80 and overBone Density Conservation AgentsbiologyAromatase InhibitorsEtidronic AcidGeneral MedicineCombined Modality Therapymedicine.anatomical_structureFemaleRisedronic Acidmedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyAntineoplastic Agents HormonalUrologyAnastrozoleBreast NeoplasmsAnastrozoleCalcium CarbonateNitrilesmedicineVitamin D and neurologyHumansBone ResorptionAgedNeoplasm StagingFemoral neckTrochanterbusiness.industryBone fractureTriazolesmedicine.diseaseSurgeryEarly breast cancer Anastrozole Osteoporosis Vertebral fractures ElderlyDietary SupplementsOrthopedic surgerybiology.proteinbusinessOsteoporotic FracturesFollow-Up Studies
researchProduct

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia.

2007

Background and study aims Endoscopic resection of esophageal squamous-cell neoplasia with curative intent is considered to be a safe and effective alternative treatment to radical surgery in cases where the neoplasia is intraepithelial or limited to the mucosal layer. These patients are at risk for recurrent malignancy in the preserved esophagus, however. We conducted a prospective study to evaluate the efficacy and safety of endoscopic resection and to analyze variables associated with recurrence in patients with mucosal or intraepithelial squamous-cell neoplasia. Patients and methods Between December 1997 and September 2005, 65 patients (mean age +/- standard deviation [SD] 62.9 +/- 9.5 y…

Endoscopic ultrasoundMalemedicine.medical_specialtyEsophageal NeoplasmsmedicineCarcinomaHumansProspective StudiesEsophagusRadical surgerySurvival rateAgedNeoplasm StagingIntraepithelial neoplasiamedicine.diagnostic_testEsophageal diseasebusiness.industryGastroenterologyMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureHigh Grade Intraepithelial NeoplasiaFemaleEsophagoscopybusinessCarcinoma in SituEndoscopy
researchProduct

A systematic review on external ear melanoma

2014

Summary Background External ear melanoma accounts for only 1% of all cutaneous melanomas, and data on its optimal management and prognosis are limited. Aim We aim to review the literature on external ear melanoma to guide surgeons in the treatment of this uncommon and peculiar pathology. Materials and methods A systematic review of English language studies on ear melanoma published from 1993 to 2013 was performed using the PubMed electronic database. Data on epidemiology, oncological treatment (tumor resection and regional lymph nodes management), and reconstruction were extrapolated from selected papers. Results The total number of patients was 858 (30 studies). The helix was the most comm…

External earmedicine.medical_specialtySkin NeoplasmsPrognosiSentinel lymph nodeSettore MED/19 - Chirurgia PlasticaSurgical FlapsBreslow ThicknessEpidemiologyBiopsymedicineHumansReconstructive Surgical ProcedureSkin NeoplasmStage (cooking)Ear ExternalMelanomaEar NeoplasmsNeoplasm Stagingmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyMelanomaLymphatic MetastasiPlastic Surgery Proceduresmedicine.diseasePrognosisOptimal managementSuperficial spreading melanomaSurgeryEar NeoplasmSurgical FlapLymphatic MetastasisSurgeryNeoplasm Recurrence LocalbusinessEar melanomaMelanoma treatmentHuman
researchProduct

Fertility outcome after radical vaginal trachelectomy: a prospective study of 212 patients.

2011

ObjectiveFor treatment in patients with early-stage cervical cancer, radical vaginal trachelectomy (RVT) as a fertility-preserving surgery can be put on a par with radical hysterectomy as to oncologic safety. Our aim was to investigate the fertility concerns and outcome.MethodsProspective collection of fertility data of patients treated with RVT. The data were collected on personal communication, by telephone, or e-mail correspondence. Descriptive statistical analysis was performed.ResultsBetween March 2005 and April 2010, 212 patients were followed up after RVT. Only 76 patients (35.9%) were seeking parenthood currently. Sixty pregnancies occurred in 50 women. Five patients (8.3%) had firs…

Fertility-preserving treatmentAdultmedicine.medical_specialtyUterine Cervical Neoplasmmedia_common.quotation_subjectRadical vaginal trachelectomyUterine Cervical NeoplasmsFertilityMiscarriageYoung AdultGynecologic Surgical ProceduresObstetrics and gynaecologyGynecologic Surgical ProcedurePregnancyEarly-stage cervical cancer; Fertility-preserving treatment; Pregnancy after cervical cancermedicineHumansFertility preservationProspective StudiesProspective cohort studymedia_commonNeoplasm StagingGynecologyCervical cancerPregnancyEctopic pregnancyObstetricsbusiness.industryPregnancy after cervical cancerMedicine (all)Pregnancy OutcomeObstetrics and GynecologyFertility PreservationMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaProspective StudieTreatment OutcomeOncologyEarly-stage cervical cancerFemalebusinessHumanInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
researchProduct

Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis

2023

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study (Clinical Trial ID: NCT05791838) aimed to report a retrospective analysis of the management and outcomes of 86 consecutive BOTs patients, 54 of which were at a reproductive age. All patients with BOTs undergoing surgical treatment from January 2010 to December 2017 were included. Data were retrospectively reviewed. High levels of Ca-125 were observed in 25.6% of the FIGO stage I patients and 58.3% of the advanced disease patients. Fertility-sparing surgery and comprehensive surgical staging were performed in 36.7% and 4…

Fertility-sparing surgeryBorderline ovarian tumorSurgical staging.Conservative surgeryMicropapillary patternSettore MED/40 - Ginecologia E Ostetricia
researchProduct

Avoiding Pitfalls in the Interpretation of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging

2016

Gadoxetic acid is extensively used in the following 3 main clinical situations: characterization of small nodules in patients with cirrhosis, preoperative staging of liver metastases, and characterization of incidentally discovered focal liver lesions. Owing to the rapid entry of gadoxetic acid into hepatocytes, the traditional features of liver tumors are modified on magnetic resonance (MR) imaging, especially during delayed phase sequences. Thus, although the added value of gadoxetic acid for the detection and characterization of focal liver lesions is now clear, its unique pharmacokinetics as well as the presence of mimicking and atypical lesions may lead to misdiagnoses. The goal of thi…

Gadolinium DTPAmedicine.medical_specialtyGadoxetic acidRadiology Nuclear Medicine and ImagingCirrhosisContrast Mediaddc:616.0757Sensitivity and Specificity030218 nuclear medicine & medical imagingMagnetic Resonance Imaging/methods03 medical and health sciences0302 clinical medicinePreoperative stagingGadolinium DTPAImage Interpretation Computer-AssistedmedicineHumansIn patientmedicine.diagnostic_testbusiness.industryLiver DiseasesLiver DiseaseImage Interpretation Computer-Assisted/methodsMagnetic resonance imagingDelayed phasemedicine.diseaseMr imagingMagnetic Resonance ImagingLiver Diseases/diagnostic imaging030211 gastroenterology & hepatologyRadiologyNuclear medicinebusinessmedicine.drugHuman
researchProduct

Imaging of Gastrointestinal Stromal Tumors: From Diagnosis to Evaluation of Therapeutic Response

2016

Once considered an obscure tumor entity with poor prognosis, gastrointestinal stromal tumors (GISTs) are nowadays recognized as the most common mesenchymal tumors of the alimentary tract. GISTs differ from other mesenchymal neoplasms at pathology since 90% of them exhibit strong immunohistochemical staining for KIT, a tyrosinase kinase growth factor receptor. In the early 2000s, the ability of imatinib mesylate, a tyrosine kinase inhibitor, to inhibit KIT established a new paradigm for cancer treatment. A reduction in lesion size may not be observed or may appear many months after therapy; thus, tumor response criteria alternative to the Response Evaluation Criteria in Solid Tumors were dev…

Gastrointestinal Stromal Tumorsdiagnostic imagingreviewResponse Evaluation Criteria in Solid Tumormultidetector computed tomographyDiagnosis DifferentialPositron-Emission TomographyHumansmagnetic resonance imagingGastrointestinal stromal tumorTomography X-Ray ComputedSettore MED/36 - Diagnostica Per Immagini E RadioterapiaGastrointestinal NeoplasmsNeoplasm Staging
researchProduct

Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors

2011

Gene DosageReceptor Protein-Tyrosine KinasesProtein-Tyrosine KinasesBiologyPrognosisPathology and Forensic MedicineCohort StudiesSurvival RateNeuroblastomaExpression (architecture)Cancer researchHumansAnaplastic lymphoma kinaseAnaplastic Lymphoma KinaseChromosome DeletionIn Situ Hybridization FluorescenceNeoplasm StagingHuman Pathology
researchProduct

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma

2011

Background: Clinical heterogeneity reflects the complexity of genetic events associated with neuroblastoma (NB). To identify the status of all described genetic loci with possible prognostic interest, high-throughput approaches have been used, but only with tumour cell content >60%. In some tumours, necrotic, haemorrhagic and/or calcification areas influence the low amount of neuroblasts. We evaluated the effect of tumour cell content in the detection of relevant aberrant genetic markers (AGM) diagnosed by fluorescence in situ hybridisation (FISH) on tissue microarrays (TMA) in NB. Methods: Two hundred and thirty-three MYCN non-amplified primary NB included in 12 TMAs were analysed. Results…

Genetic MarkersMaleCancer ResearchPathologymedicine.medical_specialtyShort CommunicationCellBiologyneuroblastomaFISHaberrant genetic markersNeuroblastomatumour cell contentGene duplicationmedicineHumansNuclear proteinneoplasmsIn Situ Hybridization FluorescenceNeoplasm StagingOncogene ProteinsN-Myc Proto-Oncogene Proteinmedicine.diagnostic_testGene AmplificationChromosome MappingInfantNuclear Proteinsprognostic factorsCancerPrognosismedicine.diseaseSurvival Ratemedicine.anatomical_structureOncologyTissue Array AnalysisGenetic markerFemaleNeoplasm stagingFluorescence in situ hybridizationBritish Journal of Cancer
researchProduct

Cytogenetic analysis of three primary Bellini duct carcinomas.

1996

Three Bellini duct carcinomas (BDC) of the kidney were cytogenetically analyzed after short-term culture. All three had clonal chromosome abnormalities: 91-92,XXY,-Y, +12, +12, -15, -16, -18, +mar (case 1); 53,XY, +2,t(2;7)(p22;q11), +der (2)t (2;7)(p22;q11), +3, +r(3),add(5)(p15), +7, -8, +12, +17, +r(17), +20, -21 (case 2); and 44-47,X,-Y, +9, +16, -21/46,XY. Some of the numerical abnormalities are shared with papillary renal cell carcinomas (PRCC)(+7, +12, +16, +17, and +20) but not with transitional renal cell carcinomas. The present findings support the previous notion that BDC are different from other types of RCC.

GeneticsAged 80 and overMaleCancer ResearchKidneyPapillary renal cell carcinomasCellBiologyAdenocarcinomaMiddle AgedMolecular biologySurvival AnalysisKidney NeoplasmsDiagnosis Differentialmedicine.anatomical_structureKaryotypingGeneticsmedicineHumansFemaleDuct (anatomy)Carcinoma Renal CellAgedNeoplasm StagingGenes, chromosomescancer
researchProduct